Upload
darshikadoshi9
View
4.369
Download
0
Tags:
Embed Size (px)
DESCRIPTION
Comparison and Contrasts of ISO 13485:2003, 21 CFR 820 and ICH Q10
Citation preview
QUALITY SYSTEMSComparison , differences and summary
Prepared and presented by,“QUALITEAM”
Ankith DevunapalliDarshika Doshi
Harsh DharamshiSindhura Gaddamanugu
Srikanth Reddy Vattipalli
Qualiteam
ComparisonBased on:
Similarities in requirements for the various aspects of a quality system.
Only those requirements that are similar in more than 2 of the assigned documents included in this section
Qualiteam
Qualiteam
Management Responsibility• Establishment of quality system, quality policy, organization,
quality planning and resources (personnel and equipment)
• Review of the effectiveness and suitability of the quality system through reviews and audits.
Purchase Controls• Establishing procedures and documents for evaluation of
suppliers, verification of the purchased product and quality control of the purchase including establishment of quality system requirements, testing of the product, personnel training and responsibility communication.
Documentation Controls• Documentation control requirements are more or less the same
in all the regulation and guidances with minute differences.• Establishment, maintenance and control of all the
documentation required as per the regulation or guidance document.
• Establishment of procedures for document approval, distribution, implementation and finally document changes.
Qualiteam
Design Controls• Establishment and maintenance of procedures for
design and development planning, design inputs, design outputs, design verification and validation, review and records
Production & Process Controls• Production processes should be developed,
conducted, controlled and monitored to ensure a conforming product.
Corrective & Preventive action• Establishment of procedures and documentation
required for correction of non conforming products as well as prevention, includes prodcedures for identification of causes of non conformity, identification of actions to be taken, verification and validation of actions to be taken, dissemination of information and maintenance of records.
Qualiteam
Identification and traceability• Establishment of documented procedures
for the identification and distinction of the product throughout the entire life cycle
• Organization should establish and maintain documented procedures for traceability of the product whenever required.
Handling ,storage, distribution and installation.• Establishment of procedures for the
proper handling, storage, distribution and installation of the product to avoid mix ups, damage , contamination and to maintain its conformity
Differences:Despite the similarities these quality systems differ from each other in several aspects
Qualiteam
21 CFR 820
• Quality system requirements applicable
to manufactuting, packaging, labelling,
storage , installation and servicing of medical
devices
ISO 13485
• Quality system requirements fulfilled by the manufacturer of medical devices
• Process Approach
ICH Q10
• Quality System requirements for manufacture of pharmaceutical drug products, biotech and biological products
• Process approachCGMP for Combination Pdts.
•Guidance document for manufacturers of Combination pdts. as well as FDA
21 CFR 820• Not applicable
ISO 13485• Some clauses based
on ISO 9000
ICH Q10• Regional GMP, ICH
Q7 and ISO QMS
CGMP for Combination Pdts.
•Guidance document for manufacturers of Combination pdts. as well as FDA Qualiteam
21 CFR 820
• Highly Defined• Establishment of
quality policy,organization,resources and review of the system
ISO 13485
• Highly defined• Additionally
includes Mgmt commitment,customer focus, review input and output
ICH Q10
• Separate clause• Additionally includes:
mgmnt of outsourced activities, purchased goods, change in product ownershipCGMP for
Combination Pdts.
•Requirement as applicable to the type of product
21 CFR 820
ISO 13485
CGMP for Combination
Products
ICH Q10
• Not highly defined• Briefly mentioned in
Phamraceutical Quality Management sys.
•Highly Defined•Requirements as mentioned in Comparison
•Applicable as 21 CFR 820 for Medical Device as PMOA
21 CFR 820 & ISO 13485: 2003
• Includes requirements for establishment ,
maintenance, approval and distribution of all
relevant documentation
ICH Q10• No equivalent
clause
CGMP for Combination
Products
• Document control requirements a part of 21
CFR 820 and 21 CFR 210/211 (whichever
applicable)
21 CFR 820 &
ISO 13485:2003
• Highly defined
ICH Q10
• Not addressed specifically
• Management responsibility related to purchase highlighted
CGMP for Combination
Pdts.
• Not addressed specifically
Qualiteam
21 CFR 820 & CGMP
combination products
ISO 13485:200
3
Q 01
•Included as a separate clause•Specific information regarding buildings, equipments and environment contamination control, manufacturing materials process validation automated processes control of inspection
•Not included as a separate clause but included under resource management and product realization •No information regarding automated processes is provided
•It is not included as a separate clause but some information provided under resourse management•No special requirements mentioned when compared to QSR and ISO
Qualiteam
21 CFR 820 & CGMP
combination products
ISO 13485:200
3
Q 01
•Included as a separate clause.•Information regarding Record Retention, device master records and device history records and complaint file is provided•General information regarding control
of records is addressed under the clause documentation requirements.•DMR and DHR are not provided.•Feedback system in place of complaint files
•No Q10 equivalent
Qualiteam
21 CFR 820, ISO 13845:2003, CGMP for combination products
• Establishment of techniques for identifying and accepting the conformity and effectiveness of the product.
ICH Q10
• Mentioned briefly under process performance and product quality control
Qualiteam
21 CFR 820, ISO 13845:2003, CGMP
for combination products
• Establishment of documented procedures for the identification, control and disposition of non conforming product and prevent their unintended use.
ICH Q10
• No special requirements• Their handling was
mentioned briefly under CAPA
Qualiteam
21 CFR 820, ISO 13845:2003, CGMP for combination products
• Establish and document procedures for avoiding any non conformity of a product and prevent their recurrence.
ICH Q10
• CAPA is not so elaborate. • No requirements for
verification, validation and management review
Qualiteam
21 CFR 820, CGMP for
combination products
• Establishment of documented procedures for labeling of the product.
• Maintain and control procedures for proper packaging of the product to avoid damage during product release
ICH Q10, ISO 13845:2003
• No special requirements
Qualiteam
21 CFR 820 and CGMP
combination products
ISO 13485:2003
Q10No special requirements are mentioned
• Identification is same as that of 21 CFR 820•Manufacturer should identify and distinguish returned medical devices from conforming products
Manufacturer should establish and maintain procedures to identify the product throughout its entire lifecycle to avoid mixups.
Qualiteam
21 CFR 820 & CGMP combination
products
ISO 13485:200
3
Q10
•It is described in detail •Manufacturer should establish, maintain and document procedures to ensure proper handling, storage,Distribution and installation of the product to avoid mix-ups , damage ,contamination and adverse effects.
There is no special requirements
It is not described in detail when compared to QSR
Qualiteam
21 CFR 820 & CGMP combination
products
ISO 13485:2003
ICH Q10 There is no special requirements
•It is similar to 21 CFR •Particular requirement for active implantable medical devices and implantable medical devices is needed
organization should establish and maintain records of traceability of medical devices which may cause a potential risk to the user. Requirements concerned with receiving in process and finished device acceptance and servicing.
Qualiteam
Additional requirements in Q10Certain requirements were found exclusively in Q10.
Emphasis was made on quality risk managementknowledge management management of change in product ownership. Each and every clause specified special requirements at
different stages of product life cycle.
Qualiteam
SUMMARY:21 CFR 820, ISO 13845:2003 and CGMP show similarities in
documentation control ,design control management responsibilities , corrective and preventive actions and nonconforming products.
21 CFR 820 and ISO 13845:2003 mention similar requirements under purchase controls with CGMP’S showing the same with respect to medical devices. Labeling and packaging control is another clause where 21 CFR 820 and CGMP’S show similar requirements.
CGMP for combination products ,ISO 13485:2003 and 21 CFR 820 also mention the same requirements for handing, storage, distribution and installation.
Qualiteam
The differences are listed below:
21 CFR 820: no requirements for planning, internal communication, product realization and its planning and absence of special requirements for sterile medical devices and customer related processes.
ISO 13845:2003 : mentioned additional requirements under management responsibility which include management commitment, customer focus, review output and input, no requirements with respect to DMF, automated process, distribution, labeling and packaging.
ICH Q10: no special requirements for documentation control, identification and traceability , labeling
and packaging., handling ,storage, distribution and installation in Q10. Non conforming products were not given special requirements under Q10. Their handling was mentioned under corrective and preventive actions. Also there was no mention of verification and validation and management review under corrective and preventive actions in Q10. Purchase controls were not highly defined.
Certain requirements were found exclusively in Q10. Emphasis was made on quality risk management, knowledge management and management of change in product ownership. Each and every clause specified special requirements at different stages of product life cycle.
CGMP for combination products : when regulated by 21 CFR 820 ,additional requirements as per 21 CFR 210 and 211 which include drug product inspection , expiration dating , testing and release for distribution ,stability testing , reserve samples and testing and approval or rejection of components , drug product containers and closure are considered .
When regulated by 21 CFR 210 and 211 , additional requirements like design controls , purchasing controls, corrective and preventive actions are considered
Qualiteam